Transformemos juntos la atención cardiovascular
Si usted es un empleador o pagador que busca una solución integral para la salud del corazón, contáctenos.
Nuestros productos
Nuestras soluciones
AliveCor, the leading innovator in FDA-cleared personal electrocardiogram (ECG) technology, today announced that the company has been named 2024 Inc. Best in Business Awards winner in the Innovation and Technology category for Kardia 12L ECG System, the world’s first AI-powered handheld 12-lead ECG system with a unique single-cable design.
FDA-cleared in June 2024, Kardia 12L ECG System uses a reduced leadset to enable faster, easier detection of 35 cardiac determinations, including heart attacks. Powered by AliveCor’s proprietary KAI 12L AI technology, the pocket-sized Kardia 12L ECG System was designed exclusively for healthcare settings and offers outstanding clinical efficiency and performance that is substantially equivalent to state-of-the-art ECG analysis solutions. The unique, simplified design makes it possible for more healthcare providers in a wider range of settings, including primary care offices, urgent care clinics, employer clinics, and rural locations, to access and integrate 12-lead ECG data into cardiac care.
“At AliveCor, we’re relentless in our pursuit to improve the patient experience and address gaps in cardiac care. We are honored to be recognized by Inc. Magazine for our efforts in expanding this critical technology into more resource-limited settings for physicians and disrupting traditional care pathways,” said Cora Locke, Chief Marketing Officer, AliveCor.
Inc.’s Best in Business Awards spotlight organizations that are solving today’s biggest challenges while demonstrating exceptional business excellence. The 2024 honorees reflect some of the most transformative ideas across all industries. This year’s recipients can be found on the award's homepage.
About the Kardia 12L ECG System
Kardia 12L ECG System is battery-operated, weighs just 0.3 pounds and can fit in a pocket – making it significantly smaller, more portable and more convenient than conventional 12-lead ECG machines. Its streamlined leadset also makes it less invasive for patients, who do not need to fully disrobe during a reading. Powered by KAI 12L - the building block for the next generation of AI-driven technologies in AliveCor’s pipeline - the device requires minimal self-guided training and is simpler to use than standard 12-lead ECG machines. Its speed and simplicity assists healthcare providers in rapid disease detection and enhancing patient experience.
About AliveCor
AliveCor, Inc., the leading provider of FDA-cleared personal electrocardiogram (ECG) technology, is transforming cardiology with its medical-grade AI solutions. AliveCor is committed to providing innovative devices and services that empower patients and physicians with personalized and actionable heart data. With over 250 million ECGs recorded, the company’s Kardia devices are the most clinically validated personal ECGs in the world and can remotely detect six of the most common heart arrhythmias in just 30 seconds. The company’s latest offering, Kardia 12L ECG System, powered by KAI 12L to detect 35 cardiac conditions (14 arrhythmias and 21 morphologies), was designed exclusively for use by healthcare providers. AliveCor's enterprise platform allows third-party providers to manage their patients’ and customers’ heart conditions simply using state-of-the-art tools that provide easy front-end and back-end integration to AliveCor technologies, addressing gaps in care and improving the treatment experience for patients across a range of disease areas. AliveCor is a privately held company headquartered in Mountain View, Calif. For more information, visit alivecor.com and follow us on LinkedIn , X , Instagram and Facebook.
Media Contacts
Su Lee
slee191@alivecor.com
(562) 544-4634
Transformemos juntos la atención cardiovascular
Si usted es un empleador o pagador que busca una solución integral para la salud del corazón, contáctenos.